Dr. Larry Corey receives public service award from American Society of Gene & Cell Therapy

Sonia Skarlatos Public Service Award recognizes person who has advanced field of gene and cell therapy
Dr. Larry Corey
Dr. Larry Corey was honored by the American Society for Gene & Cell Therapy with its Sonia Skarlatos Public Service Award on May 13. Fred Hutch File

Dr. Larry Corey of the Fred Hutchinson Cancer Research Center and Dr. Kathleen Neuzil, co-leads of the COVID-19 Prevention Network vaccine program, are the two winners of the American Society of Gene & Cell Therapy’s Sonia Skarlatos Public Service Award. The award, named after a gene therapy advocate, recognizes a person or group that has consistently fostered and enhanced the field of gene and cell therapy through governmental agencies, public policy groups, public education or nongovernmental charitable organizations.

Corey is an internationally renowned expert in virology, viral immunology and vaccine development. Most recently, he was asked to co-lead the COVID-19 Prevention Network vaccine program, which is responsible for implementing multiple COVID-19 vaccine efficacy trials in the U.S. and overseas. He is a past president and director of Fred Hutch, a professor in the Hutch’s Vaccine and Infectious Disease Division and a professor of medicine and laboratory medicine & pathology at the University of Washington. He was head of the UW Virology Division from 1978-2010 and led the AIDS Clinical Trials Group from 1987-1992. He has been the founder and principal investigator of the HIV Vaccine Trials Network since its inception in 1999.

Winners were chosen for four categories, from Outstanding New Investigator Award to Outstanding Achievement Award. The other recipient of the Sonia Skarlatos Public Service Award is Dr. Kathleen Neuzil, professor in the University of Maryland School of Medicine, who is part of the strategic team evaluating COVID-19 vaccines and therapeutics in the U.S. and was part of the study team who designed the first COVID-19 clinical vaccine trial in the U.S. “While Kathy and I appreciate the personal selection of the award and have worked incredibly hard these last 13 months, so have hundreds, if not thousands, of other colleagues who worked side by side with us,” Corey said.

The award winners were acknowledged on May 13 at 12:15 p.m. EST virtually during the ASGCT annual meeting. Now in its 24th year, the ASGCT’s annual meeting brings together over 4,500 members in the United States and worldwide. Today, the ASGCT is the largest association of individuals involved in gene and cell therapy research. 

— Adapted from an ASGCT announcement